RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 22 - per page Previous page Next page
Order by
Method of Inducing Memory B Cell Development and Terminal Differentiation
Use of IL-21 to induce differentiation of immature B cells into memory B cells and plasma cells More
The Use of an Inducible Plasmid Vector Encoding for Active TGF-beta for the Treatment of Autoimmune Diseases
Composition and method for treating inflammatory bowel disease or other autoimmune diseases More
Monoclonal antibody binding Dectin-1 with potential to treat and diagnose inflammatory diseases
MGD3 monoclonal antibody binds human Dectin-1 with high affinity and regulates production of cytokines TNF-α and Interleukin-10. MGD3 has a potential therapeutic use on inflammatory diseases. More
Multideterminant Peptides That Elicit Helper T-Lymphocyte Cytotoxic T-Lymphocyte and Neutralizing Antibody Responses Against HIV-1
Peptide constructs that may be of clinical importance in HIV/AIDS vaccine development More
Novel Methods and Compositions for Diagnosing AIDS and Other Diseases Involving Immune System Activation
New surrogate biomarker to monitor the progression of HIV infection and other conditions and diseases associated with immune system activation More
Compositions and Methods for the Treatment of Immune-Related Disease
Compositions and methods for treating immune related disease More
Ribosomal Protein S3 (RPS3), an Essential Component of NF-kappaB is a Novel and Selective Drug Target
Experiments confirm that RPS3 is essential for normal expression of specific NF-kappaB target genes, including key physiological events that require p65. More
Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis)
Novel agents that can interfere with the action of nuclear hormone receptors More
Potent Peptide for Stimulation of Cytotoxic T Lymphocyte Specific for the HIV-1 Envelope
Peptide constructs that may be of clinical importance in HIV/AIDS vaccine development More
SH2 Domain Binding Inhibitors
Grb2 SH2 domain signaling antagonists with enhanced binding affinity. More
Displaying 11..20 of 22 - per page Previous page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Sep 2011 - 95 pages - $3,500
Autoimmune Market Access in India – Market opportunities for cost-effective biosimilars
Aug 2011 - 58 pages - $5,700
Autoimmune Treatment (2009 - 2014)
Sep 2009 - 159 pages - $4,650
Autoimmune Market Access in China – New biologic therapies drive future growth
Sep 2011 - 87 pages - $5,700
Immunomodulators
Aug 2007 - 345 pages - $2,875
Autoimmune Diseases Therapy Area Pipeline Report
Nov 2010 - 399 pages - $1,495
Gastrointestinal Disorders Therapy Area Pipeline Report
Nov 2010 - 933 pages - $1,495
Psychotic disorders Therapy Area Pipeline Report
Nov 2010 - 308 pages - $1,495
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Nov 2010 - 330 pages - $1,495
Insomnia and Sleep Disorders Therapy Area Pipeline Report
Nov 2010 - 527 pages - $1,495
More Related Market Research Reports >>>

Your selection

Therapeutic target
Immune related disorders del
Autoimmune disease (non-specific) del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us